Hemoglobin S Polymerization Inhibitor [EPC] - N0000194027

Pharmacologic Code	N0000194027
Pharmacologic Name	Hemoglobin S Polymerization Inhibitor
Pharmacologic Uses	hemoglobin S polymerization inhibitor
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 3 products whose active ingredient are classified under the same pharmacologic class Hemoglobin S Polymerization Inhibitor [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	72786-101	Oxbryta	Non-Proprietary Name: Voxelotor	Tablet, Film Coated	Oral	Global Blood Therapeutics, Inc, A Subsidiary Of Pfizer Inc.	ACTIVE
	72786-102	Oxbryta	Non-Proprietary Name: Voxelotor	Tablet, Film Coated	Oral	Global Blood Therapeutics, Inc, A Subsidiary Of Pfizer Inc.	ACTIVE
	72786-111	Oxbryta	Non-Proprietary Name: Voxelotor	Tablet, For Suspension	Oral	Global Blood Therapeutics, Inc, A Subsidiary Of Pfizer Inc.	ACTIVE